Company
Pattern Bioscience
an innovator in rapid diagnosis and antibiotic susceptibility testing for bacterial infections
Also known as Pattern Bioscience, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Austin, Texas, United States
- Founded
- 2016
- Customers
- hospitals
- Legal name
- Pattern Bioscience, Inc.
- pattern.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Record updated 17 September 2026
About
We advance single-cell microbiology to make targeted antimicrobial treatment information available days sooner.
Funding snapshot
- Total raised
- $120MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $43M2025-11-18
Funding rounds
- Series D
- $43M2025-11-18, Company stated
- Round, 2025
- $44.2M2025-07-31, SEC form D sold, 6 investors
- Grant
- $22.5M2024-11-21, Company stated
- Series C
- $28.7M2023-04-27, Company stated
- Round, 2022
- $23.5M2022-12-28, SEC form D sold, 4 investors
- Series B
- $9M2020-07-14, Company stated
- Round, 2020
- $6M2020-06-29, SEC form D sold, 1 investor
- Series B
- $6.4M2020-02-04, Company stated
- Grant
- $6.8M2020-02-04, Company stated
- Round, 2019
- $6.4M2019-08-30, SEC form D sold, 13 investors
- Round, 2018
- $3.5M2018-03-20, SEC form D sold, 10 investors
Products
- Other
- Pneumonia ID/AST Panel